Skip to main content

Nigel Mackman, PhD awarded R35 grant from NHLBI/NIH

December 2, 2020
R35 grant awarded to Nigel Mackman, PhD (PI) from NHLBI/NIH The award is a 7 year grant with $600,000/year directs costs and a total amount of $6.46million. The title is “Tissue factor-dependent coagulation in thrombosis and immune responses”. The proposal will study the mechanisms of thrombosis in cancer and viral...

Patrick Ellsworth, MD – Selected to receive the American Society of Hematology (ASH) Research Restart Award

November 5, 2020
Congratulations to Patrick Ellsworth, MD, awarded the ASH Research Restart Award.  This award is for $50,000 for the twelve-month term beginning November 2020. One of the Society’s newest programs, the ASH Research Restart Award program is designed to reduce the impact that the global COVID-19 pandemic response has had on...

David Paul, PhD and Wolfgang Bergmeier, PhD publish latest research in Blood

October 20, 2020
Talin-1 is the principal platelet Rap1 effector of integrin activation PLATELETS AND THROMBOPOIESIS| September 3, 2020 Recent Blood paper publication, collaborated with Mark Ginsberg, MD at UCSD to identify a unique mechanism regulating integrin-mediated platelet adhesion at sites of vascular injury: Wofgang Bergmeier, PhD and David Paul, PhD are co-authors...

UNC part of PPG, P01 Awarded to UCSD/La Jolla Institute~ Congratulations Wolfgang Bergmeier, PhD

October 19, 2020
The National Institutes of Health hereby awards this grant ~ Congratulations to Dr. Wolfgang Bergmeier, he is part of this PPG which is spearheaded by investigators at the University of California at San Diego and the La Jolla Institute for Immunology. Project Period: 08/05/2020 – 07/31/2025 Project Title: Cellular Mechanisms...

Vaibhav Kumar MD, Hematology-Oncology fellow, publishes study defining improved thresholds for thrombosis prophylaxis in cancer in the ‘The Oncologist’”

September 27, 2020
The Oncologist “D-dimer enhances risk targeted thromboprophylaxis in ambulatory cancer patients” Background:  Thromboprophylaxis for ambulatory cancer patients is effective, although uncertainties remain on who should be targeted.  using D-dimer values from individuals enrolled to the AVERT trial, we sought to identify and validate a more efficient VTE risk threshold for...

ATVB Highly Cited Award to Nigel Mackman, PhD and Steven Grover, PhD

September 16, 2020
Congratulations to Nigel Mackman on receiving the ATVB Highly Cited Award! As a member of the Editorial Board who publish their high level science in ATVB, we will be recognizing the publication by Editorial Board members that were the most highly cited in the determination of the 2019 impact factor....

What is myocarditis? Silvio Antoniak, PhD featured research news from UNCs ‘the WELL’

September 2, 2020
What is myocarditis? How is it linked to COVID-19? And why is it a concern for athletes?  Dr. Silvio Antoniak explains- One of the more concerning side effects of COVID-19 infection is myocarditis — a once rare condition of inflammation of the heart, leading to scar tissue build-up and a...

Jean Marie Mwiza, Receives F31 Research Fellowship Award from NIH-NHLBI

September 2, 2020
Congratulations to Jean Marie Mwiza, a graduate research assistant in the Bergmeier and Wolberg Labs, for recently receiving an F31 research fellowship award from NIH’s NHLBI.  Jean Marie’s fellowship provides ongoing stipend support, beginning January, 2021, for his project, titled “Determining the Platelet Signaling Pathway(s) Critical in Venous Thrombosis Pathogenesis”.

Dr. Silvio Antoniak awarded $2.2 million grant from NIH-NHLBI

August 6, 2020
Silvio Antoniak, PhD, assistant professor in the UNC Department of Pathology and Laboratory Medicine and member of the UNC Blood Research Center and the UNC McAllister Heart Institute, was awarded a four-year, $2.2 million grant from the NIH-NHLBI to investigate the potential therapeutic approach in inhibiting PAR1 to treat chemotherapy-induced...

ATVB Publication: VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice

August 3, 2020
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Publication Lori A. Holle, Dougald M. Monroe and Alisa S. Wolberg VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice View publication

R01 awarded to Dr. Maria Aleman (PI), Dr. Raj Kasthuri and Dr. Daniel Dominguez (Co-Is) Title: Iron-sensitive RNA regulation during erythropoiesis

July 16, 2020
Congratulations- R01 awarded to Dr. Maria Aleman (PI), R01 was awarded on a $2 million (direct costs only) 5-year R01 grant; funding period (2020-2025).   Scientific team includes outstanding scientists and collaborators, Co-Investigators Dr. Raj Kasthuri and Dr. Daniel Dominguez (not pictured). Institute: NIH/NIDDK (1R01DK124773-01) Title: Iron-sensitive RNA regulation during erythropoiesis...

Congratulations to Dr. Nigel Key Elected ISTH Secretary General- 2020-2023 International Society on Thrombosis and Haemostasis

July 15, 2020
International Society on Thrombosis and Haemostasis The results have been tallied in the runoff election for the Society’s next Secretary General. Nigel Key has secured the majority of votes, and will serve in the role for the 2020-2023 term. Congratulations Dr. Key! ISTH Website